ゲノム編集の技術を活用することで、特定の標的遺伝子の改変を精密に行うことが可能になります。ゲノム編集の技術は、遺伝子研究、遺伝子治療、遺伝子の改変に関する可能性を広げます。
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $451
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Vertex Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Issued FY24 Product Revenue Guidance Above Estimates. Also, Morgan Stanley Maintained an Equal-Weight Rating on the Stock and...
Wells Fargo Maintains Overweight on Editas Medicine, Lowers Price Target to $7